Anaveon AG
Company Overview
Management
Allison Jeynes-Ellis
London, GB
Member of the board
Joint signing authority (any two to sign)
Dr. Florian Müllershausen
Basel
Member of the board
Joint signing authority (any two to sign)
Andreas Katopodis
Bottmingen
Member of the board
Joint signing authority (any two to sign)
Stephanie Maria Fernando-Krähenmann
Reinach
Joint signing authority (any two to sign)
Christoph Huber
Bottmingen
Joint signing authority (any two to sign)
Timothy Anderson
New York City, US
Member of the board
Joint signing authority (any two to sign)
Jasper Bos
Hilversum, NL
Member of the board
Joint signing authority (any two to sign)
Arkadi Khait
Brütten
Joint signing authority (any two to sign)
Gary Phillips
Choulex
Joint signing authority (any two to sign)
Roel Bulthuis
Amsterdam, NL
Member of the board
Joint signing authority (any two to sign)
Dieter Weinand
Palm Beach Shores, US
Chairperson of the board
Joint signing authority (any two to sign)
Denis Patrick
New York City, US
Member of the board
Joint signing authority (any two to sign)
Richard Sachse
Allschwil
Joint signing authority (any two to sign)
Gonzalo Garcia Gajardo
London
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | (Transfer seat) | (Transfer seat) | |||
| 2 | 9312 | 29.12.2025 | 1006528696 | 05.01.2026 | 1006528696 |
| 3 | 4852 | 07.07.2025 | 1006380854 | 10.07.2025 | 1006380854 |
| 4 | 1990 | 14.03.2025 | 1006286005 | 19.03.2025 | 1006286005 |
| 5 | 214 | 09.01.2025 | 1006227524 | 14.01.2025 | 1006227524 |
| 6 | 4137 | 24.06.2024 | 1006068900 | 27.06.2024 | 1006068900 |
| 7 | 1636 | 05.03.2024 | 1005981117 | 08.03.2024 | 1005981117 |
| 8 | 4410 | 10.07.2023 | 1005794777 | 13.07.2023 | 1005794777 |
| 9 | 7684 | 28.12.2022 | 1005643203 | 03.01.2023 | 1005643203 |
| 10 | 4947 | 26.08.2022 | 1005551352 | 31.08.2022 | 1005551352 |
Company Purpose
Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland beteiligen, solche gründen, übernehmen und mit ihnen fusionieren. Sie kann Liegenschaften und Immaterialgüterrechte im In- und Ausland erwerben, belasten und veräussern sowie durch Beschluss des Verwaltungsrates Zweigniederlassungen und Agenturen im In- oder Ausland errichten.